Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Oct 27, 2025 Infusion Pumps
View Details β
The IFU addendum revises the Preventative Maintenance schedule to align with the update introduced in the Service Manual as of June 2023.
Nov 4, 2025 Infusion Pumps Nationwide
View Details β
It has been determined that certain lots of Access 2 Reaction Vessels may contain manufacturing deformities. The bottom (round end) of the Reaction Vessel may have a small protrusion or hair like deformity. This could cause causing instrument errors (e.g., pipetting, rake, wash carousel errors) that could delay patient results.
Nov 7, 2025 Infusion Pumps Nationwide
View Details β
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Oct 27, 2025 Infusion Pumps
View Details β
Affected gowns have the incorrect expiration date on the product packaging. Product has a shelf-life of three years which is mislabeled on the product packaging as five (5) years.
Nov 12, 2025 Infusion Pumps Nationwide
View Details β
The IFU addendum revises the Preventative Maintenance schedule to align with the update introduced in the Service Manual as of June 2023.
Nov 4, 2025 Infusion Pumps Nationwide
View Details β
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Oct 27, 2025 Infusion Pumps
View Details β
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Oct 27, 2025 Infusion Pumps
View Details β
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Oct 27, 2025 Infusion Pumps
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Downstream Occlusion alarms may occur during procedures using low flow infusion rates when a check valve* is added to the Ivenix Administration Set.
Nov 3, 2025 Infusion Pumps Nationwide
View Details β
Some products packaged for lot 818-111-7 may have been packaged in pouches labeled as lot 857-53-10.
Nov 13, 2025 Infusion Pumps
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
If the screws of tube heat exchanger on the rotating scanner are not tightened well after replacing. This component may become detached and make contact with other components located within the Incisive CT systems during rotation. Other components could be damaged due to the contact with the tube heat exchanger.
Oct 29, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential issue where the IntelliVue monitors did not alarm.
Oct 31, 2025 Infusion Pumps Nationwide
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for anesthesia leakage.
Oct 20, 2025 Infusion Pumps Nationwide
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Due to complaints of increased resistance when advancing the dilator within the introducer sheath. This issue could potential result in procedural delays and/or risk of venous intimal injuries if excessive force is applied
Sep 12, 2025 Infusion Pumps Nationwide
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Olympus Corporation of the Americas
Class I - Dangerous
Potential that the ligation loop was unable to release or detach as expected during use, causing the loop to become unintentionally fixed around patient anatomy.
Oct 30, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for anesthesia leakage.
Oct 20, 2025 Infusion Pumps Nationwide
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Oct 29, 2025 Infusion Pumps
View Details β